JPS5687586A - Antiallergic and antitumoral 11oxoo1hh thiazolo*3*22a*pyrimidinee22carboxamide and intermediate therefor - Google Patents

Antiallergic and antitumoral 11oxoo1hh thiazolo*3*22a*pyrimidinee22carboxamide and intermediate therefor

Info

Publication number
JPS5687586A
JPS5687586A JP16450280A JP16450280A JPS5687586A JP S5687586 A JPS5687586 A JP S5687586A JP 16450280 A JP16450280 A JP 16450280A JP 16450280 A JP16450280 A JP 16450280A JP S5687586 A JPS5687586 A JP S5687586A
Authority
JP
Japan
Prior art keywords
11oxoo1hh
antitumoral
thiazolo
antiallergic
intermediate therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16450280A
Other languages
English (en)
Japanese (ja)
Other versions
JPS617432B2 (cs
Inventor
Baanaado Keidein Sooru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS5687586A publication Critical patent/JPS5687586A/ja
Publication of JPS617432B2 publication Critical patent/JPS617432B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP16450280A 1979-11-23 1980-11-21 Antiallergic and antitumoral 11oxoo1hh thiazolo*3*22a*pyrimidinee22carboxamide and intermediate therefor Granted JPS5687586A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (2)

Publication Number Publication Date
JPS5687586A true JPS5687586A (en) 1981-07-16
JPS617432B2 JPS617432B2 (cs) 1986-03-06

Family

ID=22258306

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16450280A Granted JPS5687586A (en) 1979-11-23 1980-11-21 Antiallergic and antitumoral 11oxoo1hh thiazolo*3*22a*pyrimidinee22carboxamide and intermediate therefor

Country Status (35)

Country Link
JP (1) JPS5687586A (cs)
KR (1) KR830004322A (cs)
AR (2) AR228859A1 (cs)
AT (1) AT380883B (cs)
AU (1) AU520995B2 (cs)
BE (1) BE886319A (cs)
CA (1) CA1143731A (cs)
CH (1) CH649299A5 (cs)
CS (1) CS241476B2 (cs)
DD (1) DD154608A5 (cs)
DE (2) DE3043979C2 (cs)
DK (1) DK151811C (cs)
EG (1) EG14929A (cs)
ES (1) ES8203363A1 (cs)
FI (1) FI67706C (cs)
FR (1) FR2470132A1 (cs)
GB (1) GB2063862B (cs)
GR (1) GR72132B (cs)
GT (1) GT198066458A (cs)
HU (1) HU179091B (cs)
IE (1) IE50404B1 (cs)
IL (1) IL61535A (cs)
IN (1) IN154926B (cs)
IT (1) IT1209373B (cs)
LU (1) LU82950A1 (cs)
NL (1) NL182565C (cs)
NO (1) NO803521L (cs)
NZ (1) NZ195596A (cs)
PH (1) PH16666A (cs)
PL (1) PL132354B1 (cs)
PT (1) PT72090B (cs)
SE (1) SE448732B (cs)
SU (1) SU1042620A3 (cs)
YU (1) YU41953B (cs)
ZA (1) ZA807293B (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS646264A (en) * 1987-03-30 1989-01-10 Daiichi Seiyaku Co Heterocyclic amine derivative
JPH029808A (ja) * 1988-03-28 1990-01-12 Janssen Pharmaceut Nv 皮膚の健康を維持または回復する薬剤
JP2013507435A (ja) * 2009-10-13 2013-03-04 トレント・ファーマシューティカルズ・リミテッド 縮合チアゾロ及びオキサゾロピリミジノン

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS646264A (en) * 1987-03-30 1989-01-10 Daiichi Seiyaku Co Heterocyclic amine derivative
JPH029808A (ja) * 1988-03-28 1990-01-12 Janssen Pharmaceut Nv 皮膚の健康を維持または回復する薬剤
JP2013507435A (ja) * 2009-10-13 2013-03-04 トレント・ファーマシューティカルズ・リミテッド 縮合チアゾロ及びオキサゾロピリミジノン

Also Published As

Publication number Publication date
FR2470132B1 (cs) 1983-07-29
FI67706C (fi) 1985-05-10
IL61535A (en) 1984-06-29
CA1143731A (en) 1983-03-29
DE3050491C2 (de) 1985-10-10
AU6459580A (en) 1981-05-28
ATA570780A (de) 1985-12-15
PL132354B1 (en) 1985-02-28
YU295080A (en) 1983-06-30
IN154926B (cs) 1984-12-22
NL182565C (nl) 1988-04-05
GT198066458A (es) 1982-05-15
DE3043979A1 (de) 1981-09-03
DE3043979C2 (de) 1986-08-21
IL61535A0 (en) 1980-12-31
IT8026176A0 (it) 1980-11-21
AU520995B2 (en) 1982-03-11
AR228859A1 (es) 1983-04-29
ES497066A0 (es) 1982-04-01
CH649299A5 (fr) 1985-05-15
PT72090A (en) 1980-12-01
IE50404B1 (en) 1986-04-16
KR830004322A (ko) 1983-07-09
BE886319A (fr) 1981-05-25
GB2063862A (en) 1981-06-10
CS241476B2 (en) 1986-03-13
AT380883B (de) 1986-07-25
IE802418L (en) 1981-05-23
FI67706B (fi) 1985-01-31
SU1042620A3 (ru) 1983-09-15
SE8008189L (sv) 1981-05-24
FI803628L (fi) 1981-05-24
DK151811C (da) 1988-06-06
DD154608A5 (de) 1982-04-07
PH16666A (en) 1983-12-13
ES8203363A1 (es) 1982-04-01
FR2470132A1 (fr) 1981-05-29
NO803521L (no) 1981-05-25
NL182565B (nl) 1987-11-02
NZ195596A (en) 1984-05-31
CS782080A2 (en) 1985-06-13
ZA807293B (en) 1981-12-30
DK413180A (da) 1981-05-24
GB2063862B (en) 1983-06-22
JPS617432B2 (cs) 1986-03-06
LU82950A1 (fr) 1981-06-04
HU179091B (en) 1982-08-28
AR231296A1 (es) 1984-10-31
SE448732B (sv) 1987-03-16
PT72090B (en) 1981-09-29
NL8006362A (nl) 1981-06-16
YU41953B (en) 1988-02-29
DK151811B (da) 1988-01-04
GR72132B (cs) 1983-09-19
EG14929A (en) 1989-01-30
IT1209373B (it) 1989-07-16
PL228008A1 (cs) 1981-12-11

Similar Documents

Publication Publication Date Title
JPS5686186A (en) Oxabicycloheptane and hepteneprostaglandin analogue
JPS5690414A (en) Integrated magneticchead structuoe and production thereof
JPS55118483A (en) 55alkyll22*44cyanophenyl**1*33dioxanes
JPS5636485A (en) 2*33dihydroo2*6*77trisubstitutedd55 acylbenzofuran
JPS5632427A (en) Novel 44fluoroo33phenoxyybenzaldehydeacetal* its manufacture* novel intermediate therefor and its manufacture
JPS5695198A (en) Ee55*22halogenovinyl**2**deoxycytidines
JPS5690086A (en) 11piperidinesulfonylurea and its manufacture
JPS56124651A (en) Lockerrhousing and lockerrcover
JPS5645480A (en) 4**substitutedd4*5**88trialkylpsoralen
JPS5645478A (en) 5**aminoalkyll4**44dialkylpsoralen
JPS5566535A (en) 44*1*11dimethylethyl**4**methoxydibenzoylmethane and said manufacture
JPS55154994A (en) Amtibiotic aa6888c and aa6888x
JPS5697276A (en) Alphaaaryll1hh1*2*44triazolee11ethanols
JPS5687586A (en) Antiallergic and antitumoral 11oxoo1hh thiazolo*3*22a*pyrimidinee22carboxamide and intermediate therefor
JPS567794A (en) 2*33dihydrooimidazo*2*11b*benzothiazoles
JPS5699475A (en) 11*88quinolyl**22pyrrolidinone
JPS55151565A (en) 5*66dihydroo111alkeneemorphanthridinee66one and its manufacture
JPS5636484A (en) 1*2*44triglycidyltriazolidinee3*55dione and its manufacture
JPS55124768A (en) Phenylmorphanes*its intermediate and its manufacture
JPS55130950A (en) Betaaalkoxyyacrylonitrile*33aminooacryonitrile and 22cyanoovinylester manufacture
JPS5620578A (en) 1*2*44triazolidinee3*55dithiones and their use
JPS55115870A (en) 2*22dimethyll1*22dihydroquinoline derivative and its manufacture and use
JPS5751755A (en) Pigment blend and manufacture
JPS5636462A (en) Imidazolylmethyleneesubstituted dihydrobenzo thiopyranones and dihydroindenones
JPS552679A (en) 33acyll22alkylland 33acyll22aryll1*3*22 benzoxazaphosphoranes and their manufacture